Livongo Health, Inc. reported consolidated unaudited earnings results for the third quarter and nine months ended September 30, 2019. For the quarter, Revenue was $46,658,000 against $18,782,000 reported a year ago. Loss from operations was $21,115,000 against $11,014,000 reported a year ago. Net loss was $19,712,000 against $10,516,000 reported a year ago. Net loss per share attributable to common stockholders, basic and diluted was $0.27 against $0.64 reported a year ago.

For the nine months, Revenue was $119,605,000 against $47,225,000 reported a year ago. Loss from operations was $52,349,000 against $21,871,000 reported a year ago. Net loss was $48,916,000 against $20,922,000 reported a year ago. Net loss per share attributable to common stockholders, basic and diluted was $1.34 against $1.29 reported a year ago.

For the fourth quarter, the company expects revenue in the range of $49.0 million and $49.5 million.

For 2019, the company expects revenue in the range of $168.5 million and $169.0 million.